• Users Online: 380
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 16  |  Issue : 3  |  Page : 262-269

Study of plasma homocysteine level in patients with bronchial asthma and its relation to asthma severity


1 Department of Chest Disease, Faculty of Medicine, Al-Azhar University, New Damietta, Egypt
2 Department of Internal Medicine and Clinical Pathology, Faculty of Medicine, Al-Azhar University, New Damietta, Egypt
3 Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, New Damietta, Egypt

Correspondence Address:
Ramadan S Abdel-Aziz
No. 102, Flat 11, Mubark 70, New Damietta, Post Office: 1105, Madinat Dmyat Al-Jdydh
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/AZMJ.AZMJ_69_18

Rights and Permissions

Background Homocysteine (HCY) may play a role in activation of immune system in some chronic diseases, like asthma and chronic obstructive pulmonary disease. Aim The aim was to study the plasma HCY values in patients with bronchial asthma and its correlation to asthma severity. Patients and methods A total of 80 patients were enrolled, and their ages ranged from 20 to 40 years. The study populations were categorized into three groups: high reversibility asthma (n=30), low reversibility asthma (n=30), and healthy nonasthmatics (Controls n=20). For all patients, full history taking, clinical examination, chest radiography, routine laboratory investigations, pulmonary function tests, and the HCY and immunoglobulin E levels were estimated. Results The HCY measurements were found to be 8.7±0.6 µmol/l in the control group, 5.5±0.2 µmol/l in patients with high reversibility asthma, and 6.1±0.8 µmol/l in patients with low reversibility asthma. So, there was a significant variance between studied groups regarding HCY levels, but both high and low reversibility groups had low HCY when compared with control group. Moreover, the high reversibility asthma had low HCY levels when compared with low reversibility groups but without significant difference. Conclusion Plasma HCY levels, instead of being increased, may be in the low normal range or decreased in patients with asthma, most probably owing to hypoxia and in the absence of factors leading to increased HCY levels.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed657    
    Printed51    
    Emailed0    
    PDF Downloaded76    
    Comments [Add]    

Recommend this journal